Skip to main content
. 2017 May 27;8(57):96791–96797. doi: 10.18632/oncotarget.18243

Figure 2. NGS output and mutation analysis.

Figure 2

(A) The coverage summary of targeted NGS for HS genetic diagnosis. (B) ANK1 c.4276C>T (p.R1426*) mutation analysis.